Alessandra Rufini, Ph.D.
Scientific Director. Senior Scientist at the LABST, Department of Biomedicine and Prevention, Rare Diseases Section, University of Rome "Tor Vergata".
LinkedinRoberto Testi, M.D.
Founder and President. Director of the LABST, Department of Biomedicine and Prevention, Head of Rare Diseases Section, University of Rome "Tor Vergata". Full Professor and Chairman of Immunology, School of Medicine, University of Rome "Tor Vergata".
LinkedinPARTNERS
CureFA Foundation
The CureFA Foundation, Rye, N.Y., USA, funds scientific projects and industry partnerships that leverage new technologies for the treatment and cure of Friedreich's Ataxia.